A Detailed Look At What Patients Experience When They Take Part In Hypertension Clinical Trials

NCT05910255 | Not Yet Recruiting

• 1 other identifier: 87814554
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

This research study aims to identify the obstacles faced by specific demographic groups of hypertension patients during their engagement in clinical trials. The study will collect in-depth information from participants and identify common factors that impede their enrollment or successful completion of these trials. By examining data from various demographic perspectives, the study aims to identify patterns impacting future hypertension patients' experiences.

Conditions

Hypertension

Keywords

Hypertension

Outcome Measures

Primary Outcomes (2)

• Number of hypertension patients who decide to join in a clinical study

  3 months

• Rate of patients who remain in a hypertension clinical study to completion

  12 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with hypertension who are actively participating in a clinical research, but have not yet completed enrollment and randomization.

You may qualify if:

• Patient is at least 18 years of age
• Diagnosis of hypertension
• Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.

You may not qualify if:

• Enrolled in another research study
• Inability to provide written informed consent
• Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Sponsors & Collaborators

• Power Life Sciences Inc.: lead

Study Sites (1)

Power Life Sciences

San Francisco, California, 94107, United States

Location

Related Publications (3)

• Margolis KL, Crain AL, Green BB, O'Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, Ziegenfuss JY, JaKa MM, Appana D, Sharma R, Kodet AJ, Trower NK, Rehrauer DJ, McKinney Z, Norton CK, Haugen P, Anderson JP, Crabtree BF, Norman SK, Sperl-Hillen JM. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials. 2022 Aug 17;23(1):673. doi: 10.1186/s13063-022-06611-3.

  PMID: 35978336 BACKGROUND

• Noone C, Dwyer CP, Murphy J, Newell J, Molloy GJ. Comparative effectiveness of physical activity interventions and anti-hypertensive pharmacological interventions in reducing blood pressure in people with hypertension: protocol for a systematic review and network meta-analysis. Syst Rev. 2018 Aug 21;7(1):128. doi: 10.1186/s13643-018-0791-9.

  PMID: 30131071 BACKGROUND

• Cimmaruta D, Lombardi N, Borghi C, Rosano G, Rossi F, Mugelli A. Polypill, hypertension and medication adherence: The solution strategy? Int J Cardiol. 2018 Feb 1;252:181-186. doi: 10.1016/j.ijcard.2017.11.075. Epub 2017 Nov 23.

  PMID: 29180263 BACKGROUND

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Officials

• Michael B Gill

  Power Life Sciences Inc.

  STUDY DIRECTOR

Central Study Contacts

Michael B Gill

CONTACT

4159004227; bask@withpower.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 9, 2023
• First Posted: June 18, 2023
• Study Start: July 1, 2024
• Primary Completion: July 1, 2025
• Study Completion: July 1, 2026
• Last Updated: June 18, 2023

Record last verified: 2023-06

Locations

US (1)